Please login to the form below

Not currently logged in
Email:
Password:

Ross Macdonald to lead Australian pharma company Hatchtech

Joins as Hatchtech prepares to initiate phase III trials of head lice treatment

Australian pharma firm Hatchtech has appointed Dr Ross Macdonald as its new CEO as the company prepares to initiate phase III trials for novel head lice treatment product DeOvo.

Dr Macdonald is currently a non-executive director of Hatchtech's board, and has worked in the pharmaceutical industry for 24 years.

Most recently, he was managing director and CEO of Living Cells Technology from August 2010 to July 2011, following a year-long spell at Sinclair Pharmaceuticals where he served as VP business development.

Prior to his time at UK-based Sinclair, he was VP corporate development for Stiefel Laboratories, which was acquired by GlaxoSmithKline in 2009 for £2.25bn.

His other previous positions include serving as VP of R&D with FH Faulding & Co Limited (acquired in 2001 by Mayne Nickless) and managing director of Soltec Research.

In addition to Dr Macdonald's appointment, Hatchtech has also secured additional capital, bringing total funds raised AUD7.8m, to enable the continued development of its head lice therapy.

“The further injection of capital confirms our investors' enthusiasm in light of the clear attainment of efficacy endpoints from our recent Phase 2b clinical trial of DeOvo,” said Hatchtech's chair, Dr Paul Kelly.

“Hatchtech is in an excellent position to complete the clinical development of DeOvo and proceed with product commercialisation.”

3rd May 2012

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...
What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...

Infographics